CRISPR Therapeutics Presents Positive Data on Allogeneic CRISPR-based CAR-T Cell Therapies at AACR 2018 – Investing News Network
Investing News Network |
CRISPR Therapeutics Presents Positive Data on Allogeneic CRISPR-based CAR-T Cell Therapies at AACR 2018
Investing News Network CRISPR Therapeutics (NASDAQ:CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced the presentation of new data from the company’s allogeneic chimeric antigen receptor T cell … |
|
ViaCyte Substantially Expands Patent Portfolio in Stem Cell-Derived Cell Replacement Therapies for Type 1 Diabetes …
PR Newswire (press release) “ViaCyte’s intellectual property covers directed differentiation to various cell types from numerous pluripotent stem cell sources, including embryonic and induced pluripotent stem cells, by multiple methods, as well as delivery and encapsulation … |
